Why is Transgene Biotek falling/rising?

As of 08-Sep, Transgene Biotek Ltd's stock price is currently at 4.00, reflecting an increase of 0.04 or 1.01%. Despite this positive movement today, the stock has shown a significant decline over the past week, down 3.61%, and a more substantial drop of 14.53% over the past month. The stock's performance today has outperformed its sector by 1.33%, but it remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a lack of sustained upward momentum. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 86.71% compared to the 5-day average, which may suggest waning interest among investors. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with a 1-week decline of 3.61% compared to a modest gain of 0.53% for the Sensex. Over the longer term, Transgene Biotek has experienced a year-to-date decline of 41.43%, while the Sensex has increased by 3.39%. This stark contrast highlights the challenges faced by Transgene Biotek in attracting investor confidence relative to the overall market. The liquidity of the stock remains adequate for trading, but the significant drop in delivery volume may indicate a cautious sentiment among investors, further contributing to the stock's struggles in the current market environment.